ilomastat has been researched along with cgs 27023a in 1 studies
| Studies (ilomastat) | Trials (ilomastat) | Recent Studies (post-2010) (ilomastat) | Studies (cgs 27023a) | Trials (cgs 27023a) | Recent Studies (post-2010) (cgs 27023a) |
|---|---|---|---|---|---|
| 103 | 0 | 45 | 72 | 3 | 12 |
| Protein | Taxonomy | ilomastat (IC50) | cgs 27023a (IC50) |
|---|---|---|---|
| Interstitial collagenase | Homo sapiens (human) | 0.031 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.0297 | |
| Stromelysin-1 | Homo sapiens (human) | 0.0256 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.0191 | |
| Lethal factor | Bacillus anthracis | 1.2 | |
| Neutrophil collagenase | Homo sapiens (human) | 0.0105 | |
| Collagenase 3 | Homo sapiens (human) | 0.0209 | |
| Matrix metalloproteinase-14 | Homo sapiens (human) | 0.023 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camodeca, C; Cuffaro, D; Gifford, V; Ito, N; Itoh, Y; Nencetti, S; Nuti, E; Orlandini, E; Rossello, A; Tuccinardi, T | 1 |
1 other study(ies) available for ilomastat and cgs 27023a
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP).
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Collagen; Drug Design; Enzyme Activation; Humans; Hydroxamic Acids; Matrix Metalloproteinase 14; Matrix Metalloproteinase Inhibitors; Molecular Dynamics Simulation; Molecular Structure; Protein Multimerization; Sulfonamides | 2019 |